Crunchbase reports that startup funding is flat this quarter. But the synthetic biology industry doesn’t seem to have gotten the memo. SynBioBeta released its Synthetic Biology Investment Report for this quarter...
Author - Calvin Schmidt
Geltor CEO Alex Lorestani’s take on a future shaped by biodesigned products
What if the secret to younger looking, healthier skin was a protein abundant in the cells of babies but rare in adults? Biodesign company Geltor introduced that secret, dubbed HumaColl21™, to attendees of the in...
Indistinguishable from magic? Meet Berkeley Lights
Researchers in biology and biotechnology often have a very difficult time making reliable measurements. We are attempting to measure units that are small and often cross-react with each other. Additionally, they usually...
Meet the 25 synthetic biology companies that raised $652M this quarter
The industry’s Class of 2019 includes many new investors and innovative startups, setting the stage for a strong year The synthetic biology industry got off to a hot start in 2019, with 25 companies raising $652 million...
Why synthetic biology investors need to look beyond Silicon Valley and Boston
Synthetic biology, the field concerned with the design and construction of novel biological systems, has received intense interest from both startup investors and the broader media. The amount of investment in the area...
These 98 synthetic biology companies raised $3.8 billion in 2018
Every year, it seems the story is the same: Synthetic biology companies make amazing advances building engineered biological products, these advances receive widespread interest, and more money pours into the field to...
Synthetic biology investors are a mix of life sciences and traditional technology investors
Entrepreneurs in synthetic biology raising new rounds of investment sometimes have a hard time finding the right investors. Traditional healthcare investors who have the expertise required to evaluate the underlying...
Twist Bioscience Files for $86.3M IPO
Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $86.3 million in...
These 33 synthetic biology companies just raised $925 million: Read SynBioBeta’s 2018 Q2 funding update
The last quarter saw the biggest funding for synthetic biology for any three-month period in history. The year started on a record-setting pace, with 27 synthetic biology companies raising $650 million in private and...
Synthetic biology companies raised over $650 million in Q1, setting the pace for another record-breaking year
In 2017, synthetic biology companies raised a record amount of funding – just over $1.8 billion for fifty two companies – driven mostly by several multi-hundred million dollar deals. This was a 50% increase...
